急性胰腺炎市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00017674
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 196
Buy Now

【研究报告】急性胰腺炎市场规模预计将从2022年的56.4977亿美元增长到2030年的88.2737亿美元;预计2022年至2030年复合年增长率为5.7%。

市场洞察和分析师观点:

由于急性胰腺炎市场规模的激增,急性胰腺炎市场规模正在快速增长。由于胆结石病例增加,急性胰腺炎病例数增加。此外,糖尿病发病率的上升也推动了市场的增长。

2022 年 9 月,GE Healthcare 因其用于 3D 和 PROPELLER 的突破性 AIR Recon DL 获得了美国 FDA 510(k) 许可成像序列。这些新功能将 AIR Recon DL 的优势扩展到几乎所有磁共振成像 (MRI) 临床程序,涵盖所有解剖结构,并实现更短的扫描时间、更好的图像质量和增强的患者体验。因此,满足客户需求的革命性技术的显着增长可能会在预测期内为急性胰腺炎市场带来新趋势。

未来趋势和挑战:

急性胰腺炎胰腺炎是胰腺的炎症性疾病。该病与发病率和死亡率增加有关,因为没有批准治疗该病的具体治疗方法,因此支持治疗作为主要治疗方案。需要一种有针对性的新型治疗策略来阻止疾病进展并改善患者预后,以解决当前急性和重症胰腺炎的疾病负担。 2023 年 2 月在国家医学图书馆发表的一篇文章重点讨论了推进急性胰腺炎治疗的 3 个主要方法——新遗传信息的临床识别和应用;新发现的血清生物标志物,即脂肪酸乙酯(FAEE);

新基因信息的临床识别与应用:

急性胰腺炎发生在35岁或发病时如果是复发性或特发性,建议对急性胰腺炎的 6 种可商业评估的遗传原因进行检测。该测试提供了有关遗传易感性的诊断概率、可能在疾病识别中发挥作用的辅助因子以及在过程早期开始治疗的合适方法的宝贵信息,而无需重复测试。

新确定的血清生物标志物——FAEE:

在一项前瞻性、盲法试验中,研究人员比较了 175 名因酒精性胰腺炎、酒精中毒、非酒精性胰腺炎住院的患者血液中 FAEE、非酯化脂肪酸和乙醇的水平和正常对照。该测试具有独特的能力,可以证明与饮酒相关的 FAEE 诊断升高。因此,可以评价酒精是酒精相关性胰腺炎的病因。

急性胰腺炎早期喂养时机的重要加速:

开始早期喂养的做法急性胰腺炎发病后通过鼻胃/鼻空肠途径进行治疗已得到多项随机对照试验的支持,并取代了喂食前让胃肠道休息直至疼痛消退的做法。这种方法可以增加肠道蠕动,减少器官衰竭、感染、住院时间和死亡率,证实闲置的肠道会导致细菌过度生长、通透性增加和细菌易位。

特定的治疗方法将在不久的将来带来新的治疗选择,以提高疗效并改善急性胰腺炎市场。

战略洞察

报告细分和范围:

急性胰腺炎市场份额根据产品、应用和最终用户进行细分。根据提供的产品,市场分为药物、诊断和其他。根据病因,急性胰腺炎市场分为胆结石、酗酒、遗传性疾病、感染等。根据最终用户,市场分为医院、诊断实验室、门诊手术中心等。根据地理位置,急性胰腺炎市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度) 、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和其他地区)南美洲和中美洲)。

细分分析:

根据产品,急性胰腺炎市场分为药物、诊断等。 2022年,诊断领域占据最大市场份额。然而,其他细分市场预计在预测期内(2022-2030年)将创下最快的复合年增长率。诊断领域的急性胰腺炎市场进一步细分为血液检查、CT扫描、粪便检查、超声波、MRI和尿液检查。血液检查主要用于诊断急性胰腺炎。血液样本中淀粉酶和脂肪酶等胰酶水平升高表明存在疾病。同样,尿液测试用于检测胰蛋白酶原-2 或淀粉酶水平,以诊断胰腺问题,包括胰腺炎。

此外,粪便弹性蛋白酶测试可测量粪便中弹性蛋白酶的含量。粪便中发现的弹性蛋白酶有限或没有发现,表明胰腺无法产生/释放足够的弹性蛋白酶和其他消化液。这种情况称为胰腺外分泌功能不全(EPI)。根据 MedlinePlus(美国国家医学图书馆)的资料,急性(短期)胰腺炎是 EPI 的病因之一。因此,粪便检查也可用于诊断急性胰腺炎。超声、CT 扫描和 MRI 等成像测试广泛用于可视化胰腺和附近组织,以识别异常或炎症。这些测试有助于确定疾病的严重程度。它可以帮助临床医生提供正确的治疗指导,因为准确的诊断对于急性胰腺炎的有效管理至关重要。

急性胰腺炎市场,按产品划分 - 2022 年和 2030 年

基于按病因分类,急性胰腺炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022年,胆结石细分市场占据最大市场份额。预计同一细分市场在预测期内(2022-2030 年)将创下最高复合年增长率。胆石症,通常称为胆结石,是胆囊中形成的消化液(例如胆固醇或胆红素)的硬化沉积物。根据约翰霍普金斯大学医学中心的说法,当胆结石阻塞患者的胰管时,就会引起胰腺炎。胆石性胰腺炎的主要症状是剧烈疼痛、发烧、黄疸、恶心等。急性胰腺炎可以通过血液检查和不同的影像设备来诊断。血液检查可以识别胰腺炎症。 CT 扫描、MRI 或超声波可以帮助诊断病情的严重程度。根据国家健康与护理卓越研究所 (NICE) 的数据,欧洲和美国成年人的胆结石患病率约为 10-15%。根据 PubMed Central 2023 年 4 月发表的一项研究,胆结石的全球发病率在 3% 到 21.9% 之间。因此,胆结石的高患病率推动了胆结石领域急性胰腺炎市场的增长。

根据最终用户,急性胰腺炎市场分为医院、诊断实验室、门诊手术中心等。 2022年,医院领域占据最大的市场份额。诊断实验室领域的急性胰腺炎市场预计在预测期内(2022-2030 年)将以 6.4% 的复合年增长率增长。急性胰腺炎主要在医院通过手术、组织切除手术和 ERCP 进行治疗。大多数手术在医院进行,因为医院提供持续的患者护理和监测。世界各地不断增长的老年人口和不断增加的医院数量正在促进急性胰腺炎市场的发展。老年人口需要住院治疗的可能性是中年成年人的两倍多。根据威科集团 2021 年 11 月发表的一项研究,约 17% 的 65 岁及以上美国人在一年中至少住院一次,而只有 8% 的 45-64 岁成年人需要住院治疗。与 45-64 岁的成年人相比,老年人的平均住院时间(5 天)相似。

区域分析:

根据地理位置,急性胰腺炎市场划分北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。北美是全球市场增长的最大贡献者,预计亚太地区在 2022 年至 2030 年期间复合年增长率最快。北美的急性胰腺炎市场分为美国、加拿大和墨西哥。 2022年,美国在该地区占据最大市场份额,预计在预测期内(2022-2030年)将继续保持主导地位。由于胆结石病例数增加和过量饮酒导致疾病负担不断增加,北美急性胰腺炎市场预计将增长。此外,医疗保健设施的技术进步也有利于北美的急性胰腺炎市场。由于大规模饮酒和胆结石病例激增,美国报告的急性胰腺炎病例数量不断增加。根据 2021 年全国药物使用与健康调查 (NSDUH),2020 年美国 12 岁及以上人口约有 1.743 亿人饮酒。药物滥用和心理健康服务管理局 (SAMHSA) 2021 年发布的数据表明,~美国有 2950 万 12 岁以上人口和约 2740 万 21 岁以上人口患有酒精使用障碍。过量饮酒是急性胰腺炎的重要诱因。根据美国疾病控制与预防中心 (CDC) 最近的一份报告,2019 年至 2020 年期间,酒精引起的急性胰腺炎死亡人数增加了 50%。根据 Medscape 的数据,美国每年每 10 万成年人中约有 40-50 例急性胰腺炎病例,该国近 275,000 例因急性胰腺炎入院。急性胰腺炎住院人数的增加推动了美国市场的增长。

行业发展和未来机遇:

主要参与者采取的各种举措急性胰腺炎市场如下:

2023年5月,皇家飞利浦宣布推出飞利浦CT 3500,这是一款新型高通量CT系统,针对常规放射学和大容量筛查项目的需求。飞利浦 CT 3500 由人工智能提供支持,包括一系列图像重建和工作流程增强功能,有助于提供一致性、速度和一次性正确的图像质量,从而帮助临床医生进行可靠的诊断并提高投资回报率,甚至2022 年 3 月,Fresenius Kabi 完成了对专业输液治疗公司 Ivenix, Inc.(“Ivenix”)的收购。 Ivenix 在费森尤斯·卡比 (Fresenius Kabi) 面向重要美国市场的产品组合中添加了下一代输液治疗平台,这为该公司提供了医院连接和互操作性方面的关键能力。 Ivenix 领先的硬件和软件产品与 Fresenius Kabi 的静脉输液和输液设备的结合将使他们能够创建全面且领先的优质产品。随着这些发展,两家公司都采取了措施,以实现高价值医疗科技领域的可持续增长。 2021年10月,三星电子(全球医疗设备公司)的子公司三星麦迪逊推出了新型V8高端超声系统为所有医疗专业人员提供增强的图像质量、可用性和便利性。竞争格局和主要公司:

急性胰腺炎市场的一些知名参与者包括雅培实验室 (Abbott Laboratories)、通用电气医疗保健技术公司 (GE HealthCare Technologies Inc)、三星医疗保健、荷兰皇家飞利浦公司、百特国际公司、Dynavax 技术公司、Actim Oy、美敦力公司、波士顿科学公司和 Fresenius Kabi AG。这些公司专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们的全球业务使他们能够为大量客户提供服务,从而扩大他们的市场份额。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the acute pancreatitis market?

Companies operating in the market are Abbott Laboratories, GE HealthCare Technologies Inc, Samsung Healthcare, Koninklijke Philips NV, Baxter International Inc, Dynavax Technologies Corp, Actim Oy, Medtronic Plc, Boston Scientific Corp, and Fresenius Kabi AG.

Which end user segment held the largest revenue (US$ Mn) in the acute pancreatitis market?

The acute pancreatitis market, by end user, is segmented into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market. However, the diagnostic laboratories segment is estimated to grow at a CAGR during 2022-2030.

Which offerings segment led acute pancreatitis market?

The acute pancreatitis market, by offerings, is segmented into medication, diagnosis, and others. In 2022, the diagnosis segment held the largest share of the market. Moreover, others segment is expected to grow at the fastest rate during 2022-2030.

What is the regional market scenario of the acute pancreatitis market?

Global acute pancreatitis market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the acute pancreatitis market during 2022–2030. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the acute pancreatitis market across the globe?

The factors driving the market include rise in pancreatic cancer cases due to acute pancreatitis and rising incidences of diabetes following acute pancreatitis.

What is meant by the acute pancreatitis market?

Acute pancreatitis is a condition where the pancreas becomes inflamed (swollen) over a short period of time. The pancreas is a small organ, located behind the stomach, that helps with digestion. Most people with acute pancreatitis start to feel better within about a week and have no further problems.

The List of Companies - Acute Pancreatitis Market

  1. Abbott Laboratories
  2. GE HealthCare Technologies Inc  
  3. Samsung Healthcare  
  4. Koninklijke Philips NV  
  5. Baxter International Inc  
  6. Dynavax Technologies Corp  
  7. Actim Oy
  8. Medtronic Plc  
  9. Boston Scientific Corp
  10. Fresenius Kabi AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports